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Introduction
Systemic sclerosis (SSc) is associated with an increased
risk of developing pulmonary fibrosis or pulmonary
arterial hypertension. Pulmonary arteriolar proliferation
in SSc might yield a reduction in the pulmonary blood
density (PBD). However, we hypothesized that PBD
would be increased in SSc due to increased pulmonary
artery pressure and distension.
Purpose
We aimed to use cardiovascular magnetic resonance
imaging (CMR) to explore the pulmonary blood volume
(PBV), the PBV variation over the cardiac cycle (PBVV),
and the PBD as possible measures of pulmonary invol-
vement in newly diagnosed SSc.
Methods
Twenty-seven SSc patients (9 men, 30-79 years, 18 lim-
ited cutaneous SSc, 3 diffuse cutaneous SSc, and 6 early
SSc) and 20 healthy subjects (13 men, 18-46 years)
underwent CMR. The PBV was calculated as the pro-
duct of cardiac output determined by velocity encoded
CMR, and the pulmonary transit time determined as the
time for a 2 ml intravenously administered contrast
b o l u st op a s sf r o mt h ep u l m o n a r yt r u n kt ot h el e f t
atrium, as previously validated. The lung volume was
determined by planimetry using transversal MR images
covering the lungs. The PBD was defined as the PBV
divided by the lung volume. Also, the blood flow in the
pulmonary artery and the pulmonary veins was mea-
sured using velocity encoded CMR. The PBVV was cal-
culated by integration of the difference in arterial and
venous pulmonary flow over the cardiac cycle.
Results
Compared to healthy subjects, SSc patients had lower
PBV (460±85 vs 602±125ml, p<0.01), lower PBD (16±5
vs 21±2%, p<0.001; 15/27 (56%) had PBD below normal
limits), but no difference in PBVV/stroke volume (40±8
vs 46±10%, p=0.12). PBD correlated with Doppler
echocardiography estimated pulmonary artery pressure
(r=-0.36, p<0.05) and the diffusion capacity for carbon
monoxide (DLCO) in the lungs (r=0.44, p=0.02), but was
not affected by pulmonary fibrosis by high-resolution
computed tomography (p=0.34).
Conclusions
Compared to healthy subjects, newly diagnosed SSc
patients have a reduced amount of blood in the pul-
monary vasculature (PBD), and PBD is inversely related
to pulmonary artery pressure. The findings are consis-
tent with an involvement of pulmonary arterioles in SSc.
Also, this is the first human study to quantify the pul-
monary blood density by CMR. Further studies are justi-
fied to assess the utility of PBD as a diagnostic and
prognostic measure of pathophysiological changes in
cardiopulmonary disease.
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